{"id":"https://openalex.org/W7225006608","doi":"https://doi.org/10.1038/s41598-026-77945-0","title":"Orally active aminosteroid RM-581 suppresses tumor growth and metastasis formation in a gemcitabine-resistant orthotopic xenograft pancreatic cancer model","display_name":"Orally active aminosteroid RM-581 suppresses tumor growth and metastasis formation in a gemcitabine-resistant orthotopic xenograft pancreatic cancer model","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225006608","doi":"https://doi.org/10.1038/s41598-026-77945-0"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-026-77945-0","doi":"https://doi.org/10.1038/s41598-026-77945-0","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-026-77945-0","pdf_url":"https://www.nature.com/articles/s41598-026-77945-0_reference.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-026-77945-0_reference.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034301403","display_name":"Donald Poirier","orcid":"https://orcid.org/0000-0002-7751-3184","observed_orcids":["https://orcid.org/0000-0002-7751-3184"]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]},{"id":"https://openalex.org/I4405256986","display_name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/04rgqcd02","country_code":"CA","type":"facility","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256986","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Donald Poirier","raw_affiliation_strings":["Department of Molecular Medicine, Faculty of Medicine, Universit\u00e9 Laval, Quebec, QC, Canada","Laboratory of Medicinal Chemistry, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center (Endocrinology and Nephrology Unit), Quebec, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Faculty of Medicine, Universit\u00e9 Laval, Quebec, QC, Canada","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center (Endocrinology and Nephrology Unit), Quebec, QC, Canada","institution_ids":["https://openalex.org/I4405256986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160243827","display_name":"Qi Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Chen","raw_affiliation_strings":["Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035454604","display_name":"Ren\u00e9 Maltais","orcid":"https://orcid.org/0000-0002-0394-1653","observed_orcids":["https://orcid.org/0000-0002-0394-1653"]},"institutions":[{"id":"https://openalex.org/I4405256986","display_name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/04rgqcd02","country_code":"CA","type":"facility","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256986","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ren\u00e9 Maltais","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center (Endocrinology and Nephrology Unit), Quebec, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center (Endocrinology and Nephrology Unit), Quebec, QC, Canada","institution_ids":["https://openalex.org/I4405256986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102962545","display_name":"Jenny Roy","orcid":"https://orcid.org/0000-0002-9928-3009","observed_orcids":["https://orcid.org/0000-0002-9928-3009"]},"institutions":[{"id":"https://openalex.org/I4405256986","display_name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/04rgqcd02","country_code":"CA","type":"facility","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256986","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jenny Roy","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center (Endocrinology and Nephrology Unit), Quebec, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center (Endocrinology and Nephrology Unit), Quebec, QC, Canada","institution_ids":["https://openalex.org/I4405256986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038891274","display_name":"Forkan Ahamed","orcid":"https://orcid.org/0000-0003-1433-4573","observed_orcids":["https://orcid.org/0000-0003-1433-4573"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Forkan Ahamed","raw_affiliation_strings":["Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"],"raw_orcid":"https://orcid.org/0000-0003-1433-4573","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083949951","display_name":"Shannon Arnold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon Arnold","raw_affiliation_strings":["Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA","institution_ids":["https://openalex.org/I4210128618"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5034301403"],"corresponding_institution_ids":["https://openalex.org/I43406934","https://openalex.org/I4405256986"],"apc_list":{"value":2690,"currency":"USD","value_usd":2690},"apc_paid":{"value":2690,"currency":"USD","value_usd":2690},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82194662,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0203000009059906,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.013799999840557575,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aminosteroids","display_name":"aminosteroids","score":0.8949999809265137},{"id":"https://openalex.org/keywords/estrane-derivatives","display_name":"estrane derivatives","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.875},{"id":"https://openalex.org/keywords/gemcitabine-resistance","display_name":"gemcitabine resistance","score":0.9710000157356262},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.828000009059906},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8500000238418579},{"id":"https://openalex.org/keywords/orthotopic-xenograft-model","display_name":"orthotopic xenograft","score":0.8799999952316284},{"id":"https://openalex.org/keywords/panc-1-cells","display_name":"PANC-1 cells","score":0.9150000214576721},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7879999876022339},{"id":"https://openalex.org/keywords/metastasis-inhibition","display_name":"metastasis suppression","score":0.9290000200271606},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.771399974822998},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7088000178337097},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5246999859809875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47920000553131104},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4772999882698059},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.45829999446868896},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.45239999890327454},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4307999908924103},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42660000920295715},{"id":"https://openalex.org/C2777996000","wikidata":"https://www.wikidata.org/wiki/Q7130412","display_name":"Pancreatic tumor","level":4,"score":0.4025999903678894},{"id":"https://openalex.org/C2778764654","wikidata":"https://www.wikidata.org/wiki/Q9618","display_name":"Pancreas","level":2,"score":0.3862999975681305},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.35359999537467957},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34619998931884766},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.34459999203681946},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32339999079704285},{"id":"https://openalex.org/C2777299880","wikidata":"https://www.wikidata.org/wiki/Q413370","display_name":"Tegafur","level":3,"score":0.31769999861717224},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3034000098705292},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.29989999532699585},{"id":"https://openalex.org/C3017990168","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Orally active","level":3,"score":0.29989999532699585},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.2816999852657318},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.28060001134872437},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.26969999074935913},{"id":"https://openalex.org/C2778117688","wikidata":"https://www.wikidata.org/wiki/Q264024","display_name":"Animal model","level":2,"score":0.2678000032901764},{"id":"https://openalex.org/C2777928079","wikidata":"https://www.wikidata.org/wiki/Q2677027","display_name":"Rat\u00f3n","level":2,"score":0.2635999917984009}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1038/s41598-026-77945-0","doi":"https://doi.org/10.1038/s41598-026-77945-0","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-026-77945-0","pdf_url":"https://www.nature.com/articles/s41598-026-77945-0_reference.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1038/s41598-026-77945-0","doi":"https://doi.org/10.1038/s41598-026-77945-0","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-026-77945-0","pdf_url":"https://www.nature.com/articles/s41598-026-77945-0_reference.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320334506","display_name":"Canadian Institutes of Health Research","ror":"https://ror.org/01gavpb45"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225006608.pdf","grobid_xml":"https://content.openalex.org/works/W7225006608.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1469262892","https://openalex.org/W1973237225","https://openalex.org/W1982150095","https://openalex.org/W1993452986","https://openalex.org/W2044588235","https://openalex.org/W2049659810","https://openalex.org/W2084726673","https://openalex.org/W2115579238","https://openalex.org/W2126564019","https://openalex.org/W2566998216","https://openalex.org/W2570449624","https://openalex.org/W2584994931","https://openalex.org/W2594903924","https://openalex.org/W2771641984","https://openalex.org/W2789587766","https://openalex.org/W2873046237","https://openalex.org/W2885940270","https://openalex.org/W2998063956","https://openalex.org/W3080868494","https://openalex.org/W3082295535","https://openalex.org/W3126553741","https://openalex.org/W3158143408","https://openalex.org/W4206257248","https://openalex.org/W4382060824","https://openalex.org/W4390946922","https://openalex.org/W4392640170","https://openalex.org/W4404493940","https://openalex.org/W4414397416","https://openalex.org/W4416925880","https://openalex.org/W7140788868"],"related_works":["https://openalex.org/W4409631188","https://openalex.org/W2885940270","https://openalex.org/W2809668133","https://openalex.org/W2396147170","https://openalex.org/W2317719962","https://openalex.org/W1974473042","https://openalex.org/W2122175161","https://openalex.org/W4406241765","https://openalex.org/W2163864029","https://openalex.org/W3106485247"],"abstract_inverted_index":{"New":[0],"agents":[1],"with":[2,73,100,150,165],"distinct":[3],"mechanisms":[4],"of":[5,50,78,140,148,169],"action":[6],"are":[7],"urgently":[8],"needed":[9,31],"to":[10,32,43,88],"overcome":[11],"drug":[12],"resistance":[13],"and":[14,82,117,122,135,161,180],"improve":[15],"survival,":[16],"particularly":[17],"in":[18,35,54,68,110],"highly":[19],"lethal":[20],"cancers.":[21],"The":[22,146],"estrane":[23],"derivative":[24],"RM-581,":[25],"designed":[26],"through":[27],"structure\u2013activity":[28],"relationship":[29],"studies,":[30],"demonstrate":[33],"efficacy":[34],"poor-prognosis":[36],"cancer":[37,97],"models,":[38],"such":[39],"as":[40,194],"pancreatic":[41,96],"cancer,":[42],"validate":[44],"its":[45],"therapeutic":[46],"potential.":[47],"Oral":[48],"administration":[49],"RM-581":[51,79,106,126,149,155,193],"(30":[52],"mg/kg)":[53],"female":[55,101],"mice":[56,142],"revealed":[57],"improved":[58],"pharmacokinetic":[59],"parameters":[60],"(C":[61],"max":[62],",":[63],"AUC,":[64],"bioavailability)":[65],"when":[66],"formulated":[67],"Propylene":[69],"glycol:":[70],"DMSO,":[71],"compared":[72],"Glycerol:":[74],"DMSO.":[75],"Plasma":[76],"levels":[77],"increased":[80],"dose-dependently,":[81],"once-daily":[83],"dosing":[84],"produced":[85],"exposure":[86],"comparable":[87],"twice-daily":[89],"administration.":[90],"In":[91],"an":[92],"orthotopic":[93],"PANC-1":[94],"human":[95],"xenograft":[98],"model":[99],"nu/nu":[102],"mice,":[103],"orally":[104],"administered":[105],"inhibited":[107],"tumor":[108,131],"growth":[109,132],"a":[111,185,195],"dose-dependent":[112],"manner":[113],"by":[114,133],"11%,":[115],"54%,":[116],"74%":[118],"at":[119,127],"10,":[120],"40":[121],"80":[123,128],"mg/kg,":[124],"respectively.":[125],"mg/kg":[129],"suppressed":[130],"74\u201395%":[134],"prevented":[136,153],"metastasis,":[137],"whereas":[138],"33%":[139],"control":[141],"developed":[143],"metastatic":[144],"lesions.":[145],"combination":[147],"Pravastatin":[151],"also":[152],"metastasis.":[154],"was":[156],"well":[157],"tolerated":[158],"during":[159],"35-":[160],"48-day":[162],"treatment":[163],"periods,":[164],"no":[166],"clinical":[167,202],"signs":[168],"toxicity,":[170],"including":[171],"stable":[172],"body":[173],"weight,":[174],"normal":[175,181],"organ":[176],"appearance,":[177],"unremarkable":[178],"histopathology,":[179],"animal":[182],"behavior,":[183],"indicating":[184],"favorable":[186],"safety":[187],"profile.":[188],"Together,":[189],"these":[190],"findings":[191],"position":[192],"promising":[196],"preclinical":[197],"candidate":[198],"warranting":[199],"advancement":[200],"into":[201],"development.":[203]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-01T00:00:00"}